A detailed history of Ardevora Asset Management LLP transactions in Exact Sciences Corp stock. As of the latest transaction made, Ardevora Asset Management LLP holds 80,461 shares of EXAS stock, worth $4.78 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
80,461
Previous 140,253 42.63%
Holding current value
$4.78 Million
Previous $9.57 Million 37.78%
% of portfolio
0.53%
Previous 0.47%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024

SELL
$59.06 - $75.72 $3.53 Million - $4.53 Million
-59,792 Reduced 42.63%
80,461 $5.95 Million
Q3 2023

Oct 25, 2023

SELL
$65.94 - $99.04 $3.68 Million - $5.53 Million
-55,847 Reduced 28.48%
140,253 $9.57 Million
Q2 2023

Jul 06, 2023

BUY
$62.68 - $95.05 $12.3 Million - $18.6 Million
196,100 New
196,100 $18.4 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.5B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Ardevora Asset Management LLP Portfolio

Follow Ardevora Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ardevora Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on Ardevora Asset Management LLP with notifications on news.